We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
We know most of what will be said regarding income ,I’m hoping we get a bit more info on the DSM / ByHealth agreements , and progress on blue cap ,but I won’t be holding my breath
Sounds like someone's looking forward to the results in Sept..
That was H1 , H2 full year was £173k ,so £28k losses in second half .
Half year results Loss of £145k;nearly break even?
Looking at the figures again the loss in the second half were £28k , very close to break even !
DP64,
RE: "where else do you post?"
I don't. I only post on this board (LSE Provexis Share Chat) and very, very occasionally on the ADVFN Provexis chat board.
As for my other investments. I would rather keep that to myself.
Hi gixer,
Just a matter of interest what are your other investments and where else do you post?
everhopeful, RE: I find it amazing that people just have one investment interest
Not sure if you are referring to me on that comment but the fact that I only post on the PXS board does not mean I don't have shares in other companies.
As for finding info. I have had many years of practice on Provexis
wellsite, don't worry, if I find any news that could change the share price I will share it here. (at around 8:15am) :)
My money is gix tells us we have blue cap before Mr Ford does
W;-}$
I didn't think you were it was tongue in cheek. It seems to me that you need to have help in finding these new snippets . if not you are a very good sleuth. I find it amazing that people just have one investment interest , I have 10 shares in 4 different sectors.
Thank you for the kind words but no thanks.
:-)
Hi gixer,
No matter whoever you are, you are doing a wonderful job for the share holders. Even I will nominate you as a board member.
Tomatoes and lead plates don't mix - ask Emperor Nero !!!
https://www.smithsonianmag.com/arts-culture/why-the-tomato-was-feared-in-europe-for-more-than-200-years-863735/
DP64/everhopeful,
I can assure you that I am not IF.
everhopeful,
"Clinical studies conducted in China are typically required to obtain the necessary regulatory clearances in China, and a significant investment in eight separate Fruitflow studies has been undertaken at By-Health's expense."
"The five completed studies showed excellent results in use for Fruitflow, and they provide strong evidence for
By-Health in its regulatory submissions to the State Administration for Market Regulation (SAMR), China's top
market regulator. Regulatory submissions to the SAMR are also supported by the Company’s existing
European Food Safety Authority (‘EFSA’) health claim for Fruitflow."
If gixer is IF then he is doing his job. Keep it up. We are very happy with you.
at 3.18 there is displayed the EFSA FF cert from 2009 , you wonder why if they are honouring that did they bother with Blue status ? It would have involved pretty much the exact same tests .
How the hell does Gixer find this stuff ? maybe Gixer is IF ?
wellsite,
RE: Screenshot
Might be wrong but I got the impression that, in past history, tomatoes were regarded as dangerous/poisonous.
This guy ate lots and is still alive.
:)
gixer,
Many thanks for the post. Wonderful video. I am sure that was prepared by some top professional. Hope all these will direct to new top direction.
gixer
I guess the screenshot is supported by a BH study they did many years back saying FF is safe....
Saturday's snippet mentioned microcirculation ? Looks pretty important and to me consumers would get - presumably would need an EFSA stamp to put on a bottle in europe
" by maintaining normal blood flow and microcirculation in vivo."
Microcirculation
The microcirculation is the terminal vascular network of the systemic circulation consisting of microvessels with diameters <20 µm. These microvessels consist of arterioles, post-capillary venules, capillaries, and their (sub) cellular constituents (Fig. 1). The microcirculation is the final destination of the cardiovascular system and is ultimately responsible for oxygen transfer from the red blood cells (RBC) in the capillaries to the parenchymal cells where oxygen is delivered to meet the energy requirements of the tissue cells in support of their functional activity. Other functions of the microcirculation include the regulation of solute exchange between the intravascular and tissular space and is responsible for the transport of all blood-borne hormones and nutrients to the tissue cells including mediating the functional activity of the immune system and hemostasis. It is arguably the most important compartment of the cardiovascular system, since it is in direct contact with the parenchymal cells, which rely on its proper function to maintain their viability to support organ function.
A new video from BINH
https://www.zhihu.com/question/393907249/answer/2659621770
No English subtitles unfortunately but I think you get the idea.
http://postimg.cc/S25TFgqJ
Posted this on the 4th of August but it is now reviewed and published.
https://www.frontiersin.org/articles/10.3389/fnut.2022.961301/full?utm_source=F-NTF&utm_medium=EMLX&utm_campaign=PRD_FEOPS_20170000_ARTICLE
Water-soluble tomato concentrate modulates shear-induced platelet aggregation and blood flow in vitro and in vivo
"Conclusion
For the first time, we showed that WSTC can inhibit SIPA by affecting binding between integrin GP Ib and vWF in vitro. We also demonstrated the beneficial effects of WSTC on platelet hyperactivity resulting from strenuous exercise and inflammation by maintaining normal blood flow and microcirculation in vivo."
Just shy of £20k gone through at .90 on Aquis
Mr 1213 was paying 9.46 this Am and 12.13 at the close
Date Time Trade Prc Volume Buy/Sell Value
25-Aug-22 15:46:49 0.806 23,610 Sell* 190.30 O
25-Aug-22 14:12:33 0.80 310 Sell* 2.48 O
25-Aug-22 14:12:33 1.00 642 Buy* 6.42 O
25-Aug-22 14:12:33 0.80 490,000 Sell* 3,920 A
25-Aug-22 13:47:46 1.00 1,213 Buy* 12.13 O
25-Aug-22 13:47:46 0.80 1,200 Sell* 9.60 O
25-Aug-22 13:47:46 0.80 150 Sell* 1.20 O
25-Aug-22 13:47:46 0.80 393 Sell* 3.14 O
25-Aug-22 13:47:46 1.00 1,213 Buy* 12.13 O
25-Aug-22 13:47:46 1.00 1,200 Buy* 12.00 O
25-Aug-22 13:47:46 0.80 900 Sell* 7.20 O
25-Aug-22 13:47:46 1.00 600 Buy* 6.00 O
25-Aug-22 13:47:46 1.00 99 Buy* 0.99 O
25-Aug-22 13:47:46 1.00 1,213 Buy* 12.13 O
An RNS was issued for that on the 17th May and admission for trading the shares on the 23rd.
Looked like they were sold on the 27th.